Cost-utility analysis of high-dose melphalan with autologous blood stem cell support vs. melphalan plus prednisone in patients younger than 60 years with multiple myelomaGULBRANDSEN, Nina; WISLØFF, Finn; NORD, Erik et al.European journal of haematology. 2001, Vol 66, Num 5, pp 328-336, issn 0902-4441Article

Early response predicts thalidomide efficiency in patients with advanced multiple myelomaWAAGE, Anders; GIMSING, Peter; WISLÖFF, Finn et al.British journal of haematology. 2004, Vol 125, Num 2, pp 149-155, issn 0007-1048, 7 p.Article

Hepatocyte growth factor in myeloma patients treated with high-dose chemotherapySEIDEL, Carina; LENHOFF, Stig; BRABRAND, Sigmund et al.British journal of haematology. 2002, Vol 119, Num 3, pp 672-676, issn 0007-1048, 5 p.Article

Direct Hospital Resource Utilization and Costs of Treating Patients with Multiple Myeloma in Southwest Sweden : A 5-Year Retrospective AnalysisGHATNEKAR, Ola; ALVEGARD, Thor; CONRADI, Nils et al.Clinical therapeutics. 2008, Vol 30, Num 9, pp 1704-1713, issn 0149-2918, 10 p.Article

Impact of age on survival after intensive therapy for multiple myeloma : a population-based study by the nordic myeloma study groupLENHOFF, Stig; HJORTH, Martin; JOHNSEN, Hans E et al.British journal of haematology. 2006, Vol 133, Num 4, pp 389-396, issn 0007-1048, 8 p.Article

Secondary autoimmune diseases occurring after HSCT for an autoimmune disease: a retrospective study of the EBMT Autoimmune Disease Working PartyDAIKELER, Thomas; LABOPIN, Myriam; WULFFRAAT, Nico et al.Blood. 2011, Vol 118, Num 6, pp 1693-1698, issn 0006-4971, 6 p.Article

Cyclophosphamide Plus Dexamethasone Is an Efficient Initial Treatment Before High-dose Melphalan and Autologous Stem Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma : Results of a Randomized Comparison With Vincristine, Doxorubicin, and DexamethasoneMELLQVIST, Ulf-Henrik; LENHOFF, Stig; JOHNSEN, Hans E et al.Cancer. 2008, Vol 112, Num 1, pp 129-135, issn 0008-543X, 7 p.Article

Osteopontin is an adhesive factor for myeloma cells and is found in increased levels in plasma from patients with multiple myelomaSTANDAL, Therese; HJORTH-HANSEN, Henrik; SUNDAN, Anders et al.Haematologica (Roma). 2004, Vol 89, Num 2, pp 174-182, issn 0390-6078, 9 p.Article

Rapid and effective CD3 T-cell depletion with a magnetic cell sorting program to produce peripheral blood progenitor cell products for haploidentical transplantation in children and adultsDYKES, Josefina H; TOPORSKI, Jacek; JULIUSSON, Gunnar et al.Transfusion (Philadelphia, PA). 2007, Vol 47, Num 11, pp 2134-2142, issn 0041-1132, 9 p.Article

Intensive therapy for multiple myeloma in patients younger than 60 years. Long-term results focusing on the effect of the degree of response on survival and relapse pattern after transplantationLENHOFF, Stig; HJORTH, Martin; FORSBERG, Karin et al.Haematologica (Roma). 2006, Vol 91, Num 9, pp 1228-1233, issn 0390-6078, 6 p.Article

High frequencies of chromosomal aberrations in multiple myeloma and monoclonal gammopathy of undetermined significance in direct chromosome preparationNILSSON, Therese; LENHOFF, Stig; RYLANDER, Lars et al.British journal of haematology. 2004, Vol 126, Num 4, pp 487-494, issn 0007-1048, 8 p.Article

Should the standard dimethyl sulfoxide concentration be reduced? Results of a European Group for Blood and Marrow Transplantation prospective noninterventional study on usage and side effects of dimethyl sulfoxideMORRIS, Curly; DE WREEDE, Liesbeth; VAN IMHOFF, Gustaaf W et al.Transfusion (Philadelphia, PA). 2014, Vol 54, Num 10, pp 2514-2522, issn 0041-1132, 9 p., 1Article

Prognostic factors for survival in patients with advanced renal cell carcinoma undergoing nonmyeloablative allogeneic stem cell transplantationPECCATORI, Jacopo; BARKHOLT, Lisbeth; MASSENKEIL, Gero et al.Cancer. 2005, Vol 104, Num 10, pp 2099-2103, issn 0008-543X, 5 p.Article

A pooled analysis of karyotypic patterns, breakpoints and imbalances in 783 cytogenetically abnormal multiple myelomas reveals frequently involved chromosome segments as well as significant age- and sex-related differencesNILSSON, Thérèse; HÖGLUND, Mattias; LENHOFF, Stig et al.British journal of haematology. 2003, Vol 120, Num 6, pp 960-969, issn 0007-1048, 10 p.Article

Serum insulinlike growth factor is not elevated in patients with multiple myeloma but is still a prognostic factorSTANDAL, Therese; BORSET, Magne; LENHOFF, Stig et al.Blood. 2002, Vol 100, Num 12, pp 3925-3929, issn 0006-4971, 5 p.Article